Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides
Nicolás Ortonne, Sabine Le Gouvello, Reka Tabak, et al.
Experimental Dermatology (2012) Vol. 21, Iss. 6, pp. 461-463
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Advances in targeted therapy for malignant lymphoma
Li Wang, Wei Qin, Yujia Huo, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 101
Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
Xiangjun Liu, Shanzhao Jin, Simeng Hu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma
Anne Marie‐Cardine, Nicolas Viaud, Nicolas Thonnart, et al.
Cancer Research (2014) Vol. 74, Iss. 21, pp. 6060-6070
Closed Access | Times Cited: 69
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis
Yuanshen Huang, Ivan V. Litvinov, Yang Wang, et al.
Oncotarget (2014) Vol. 5, Iss. 12, pp. 4418-4425
Open Access | Times Cited: 61
Novel targeted therapies of T cell lymphomas
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 34
Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia
Aharon G. Freud, Shuchun Zhao, Sibing Wei, et al.
American Journal of Clinical Pathology (2013) Vol. 140, Iss. 6, pp. 853-866
Open Access | Times Cited: 40
KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting
Maxime Battistella, Christophe Lebœuf, C. Ram‐Wolff, et al.
Blood (2017) Vol. 130, Iss. 26, pp. 2900-2902
Open Access | Times Cited: 38
Brentuximab vedotin in T-cell lymphoma
Carrie Van Der Weyden, Michael Dickinson, James C. Whisstock, et al.
Expert Review of Hematology (2018) Vol. 12, Iss. 1, pp. 5-19
Closed Access | Times Cited: 34
Novel and Future Therapeutic Drugs for Advanced Mycosis Fungoides and Sézary Syndrome
Tomonori Oka, Tomomitsu Miyagaki
Frontiers in Medicine (2019) Vol. 6
Open Access | Times Cited: 31
Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR 3 DL 2 marker
Marie Roelens, Adèle de Masson, C. Ram‐Wolff, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 6, pp. 1415-1422
Closed Access | Times Cited: 30
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma
Alexandra Victoria Ion, Iris Maria Popa, Laura Papagheorghe, et al.
Disease Markers (2016) Vol. 2016, pp. 1-8
Open Access | Times Cited: 30
KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma
Maxime Battistella, Anne Janin, Francette Jean-Louis, et al.
British Journal of Dermatology (2016) Vol. 175, Iss. 2, pp. 325-333
Closed Access | Times Cited: 28
Oncogenic alterations in KIR3DL1 in cutaneous acral CD8+ lymphoproliferative disorder
Marion Wobser, Silke Appenzeller, Sabine Roth, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 5, pp. 816-822
Closed Access | Times Cited: 2
Expression of CD164 on Malignant T cells in Sézary Syndrome
Emmanuella Guenova, Desislava Ignatova, Yuan Chang, et al.
Acta Dermato Venereologica (2015) Vol. 96, Iss. 4, pp. 464-467
Open Access | Times Cited: 23
Cell signaling in cutaneous T‐cell lymphoma microenvironment: promising targets for molecular‐specific treatment
Natalia Rendón‐Serna, Luis Alfonso Correa Londoño, Margarita María Velásquez‐Lopera, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 12, pp. 1462-1480
Closed Access | Times Cited: 16
Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
Christian Schmitt, Anne Marie‐Cardine, Armand Bensussan
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 20
Membrane expression of NK receptors CD160 and CD158k contributes to delineate a unique CD4+ T‐lymphocyte subset in normal and mycosis fungoides skin
Nouhoum Sako, Valérie Schiavon, T. Bounfour, et al.
Cytometry Part A (2014) Vol. 85, Iss. 10, pp. 869-882
Open Access | Times Cited: 17
KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target
Morgane Cheminant, Ludovic Lhermitte, Julie Bruneau, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1522-1532
Open Access | Times Cited: 8
New targeted treatments for cutaneous T-cell Lymphomas
M. Bagot
Indian Journal of Dermatology (2017) Vol. 62, Iss. 2, pp. 142-142
Open Access | Times Cited: 14
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma
Carrie Van Der Weyden, M. Bagot, Paul J. Neeson, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 8, pp. 691-697
Closed Access | Times Cited: 12
Primary cutaneous aggressive epidermotropic CD8+ T‐cell lymphoma with KIR3DL2 and NKp46 expression in a human immunodeficiency virus carrier
Raymond Karkouche, S. Oro, Sabine Le Gouvello, et al.
Journal of Cutaneous Pathology (2014) Vol. 42, Iss. 3, pp. 199-205
Closed Access | Times Cited: 11
KIR3DL2 expression in patients with adult T-cell lymphoma/leukaemia
Charlotte Hurabielle, Christophe Lebœuf, C. Ram‐Wolff, et al.
British Journal of Dermatology (2018) Vol. 179, Iss. 1, pp. 197-199
Closed Access | Times Cited: 11
Transcriptomic changes during stage progression of mycosis fungoides
Maggie Z. X. Xiao, Dylan Hennessey, Aishwarya Iyer, et al.
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 520-531
Open Access | Times Cited: 8
NKp46 regulates the production of serine proteases and IL‐22 in human mast cells in urticaria pigmentosa
Chiyuki Ueshima, Tatsuki R. Kataoka, Masahiro Hirata, et al.
Experimental Dermatology (2015) Vol. 24, Iss. 9, pp. 675-679
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top